Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Friday, March 14, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Tags
Allergan
Tag:
Allergan
Latest Pharma-News
FDA provides Biologics License Application for Abicipar pegol
admin
-
June 27, 2020
0
Latest Pharma-News
FDA Accepts sBLA for BOTOX® (onabotulinumtoxinA) for the Treatment of Pediatric Patients with Neurogenic Detrusor Overactivity
admin
-
June 23, 2020
0
Latest Pharma-News
AbbVie completes acquisition of Allergan
admin
-
May 14, 2020
0
Latest Pharma-News
AstraZeneca recovery of global rights to brazikumab from Allergan completed
admin
-
May 12, 2020
0
Latest Pharma-News
AbbVie Announces Extension of Expiration Date for Allergan Notes
admin
-
May 6, 2020
0
Latest Pharma-News
FDA grant Approval For Allergan’s durysta (Bimatoprost Implant) for Open-Angle Glaucoma Or Ocular Hypertension Patients
admin
-
March 6, 2020
0
- Advertisment -
Most Read
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices
February 10, 2025
Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium
February 3, 2025
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
February 3, 2025
Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG
January 24, 2025